David Booty Doherty Jr.

David Doherty practices at UT Physicians in Houston, Texas.

David Doherty's NPI, 1528333770, was assigned on March 20, 2012. David Doherty graduated from McGovern Medical School in 2013. David Doherty holds Texas license S0278.

David Doherty's primary practice is UT Physicians, at 6410 Fannin St, Houston, TX 77030 in Harris County. The practice phone is (832) 325-7325.

David Doherty's primary practice is UT Physicians in Houston, Texas. David Doherty is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is UT Physicians. Dmand AI also links David Doherty to 4 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where David Doherty practices, 7 sites in all. Vendor and product names are available with a free account.

Adult reconstructive orthopaedic surgery is David Doherty's primary specialty in the NPI Registry, under taxonomy code 207XS0114X. David Doherty is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has David Doherty's licenses on file in 2 states: Texas and North Carolina.

Dmand AI lists amputation, arthritis, bursitis, hip replacement, joint pain, knee injury, knee replacement and lower back pain among the conditions David Doherty treats.

CMS data shows 1,220 Medicare services from David Doherty across 16 procedure codes in 2024, for 280 Medicare patients. Medicare paid $110,903 for them.

CMS counts 280 Medicare patients who saw David Doherty in 2024. The largest group is 65 to 74, with 147 patients. 75% of them have arthritis, and 75% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts David Doherty's median patient age at 70, with 63% women.

In 2024, David Doherty wrote 1,455 Medicare Part D claims for 258 patients. 99% of them were for generic drugs. CMS names the drug for 1,375 of them, across 14 drugs with 11 or more claims each, at $8,313 in total drug cost. In 2023, CMS named 1,458 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for David Doherty for performance year 2024, reported as part of a group. David Doherty accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 52 procedures of knee replacement by David Doherty, more than 80% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to David Doherty, published from 2018 to 2025. 2025 was the busiest year, with 2. The most frequent topics are Femur, Prosthesis Design and Arthroplasty, Replacement, Knee. David Doherty's most frequent co-authors are Nancy A. Perrier, MD, Vinay Vanodia, MD and Joshua David Harris, MD.

CMS Open Payments shows 56 general payments to David Doherty from 10 drug and device companies from 2018 to 2025. Education make up the largest share, 70% of the total. Smith & Nephew, Inc. paid the most, $17,381.

Dmand AI lists 2 awards for David Doherty, most recently American Orthopedic Association Emerging Leader in 2017.

David Doherty graduated from McGovern Medical School in 2013. David Doherty is a member of AOA, AAOS and AAHKS.

David Doherty is in network with 21 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.